Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

PHASE4CompletedINTERVENTIONAL
Enrollment

1,120

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

September 30, 2006

Conditions
HypertensionHyperlipidemia
Interventions
DRUG

Amlodipine/atorvastatin single pill

Trial Locations (102)

1000

Pfizer Investigational Site, Ljubljana

1083

Pfizer Investigational Site, Budapest

1106

Pfizer Investigational Site, Budapest

1115

Pfizer Investigational Site, Budapest

1300

Pfizer Investigational Site, Lisbon

1420

Pfizer Investigational Site, Braine-l'Alleud

1780

Pfizer Investigational Site, Wemmel

2000

Pfizer Investigational Site, Maribor

2410

Pfizer Investigational Site, Leiria

2610

Pfizer Investigational Site, Wilrijk

3000

Pfizer Investigational Site, Coimbra

3040

Pfizer Investigational Site, S. Martinho Do Bispo

3360

Pfizer Investigational Site, Bierbeek

3526

Pfizer Investigational Site, Miskolc

4000

Pfizer Investigational Site, Porto

4043

Pfizer Investigational Site, Debrecen

4100

Pfizer Investigational Site, Seraing

6000

Pfizer Investigational Site, Kecskemét

6310

Pfizer Investigational Site, Izola

6534

Pfizer Investigational Site, Gozée

7100

Pfizer Investigational Site, Szekszárd

7624

Pfizer Investigational Site, Pécs

8000

Pfizer Investigational Site, Bruges

Pfizer Investigational Site, Faro

8210

Pfizer Investigational Site, Zedelgem

9200

Pfizer Investigational Site, Mosonmagyaróvár

9840

Pfizer Investigational Site, De Pinte

10133

Pfizer Investigational Site, Torino

11527

Pfizer Investigational Site, Athens

14100

Pfizer Investigational Site, Asti

15127

Pfizer Investigational Site, Melíssia

16132

Pfizer Investigational Site, Genova

18526

Pfizer Investigational Site, Pireaus

20014

Pfizer Investigational Site, Donostia / San Sebastian

20059

Pfizer Investigational Site, Vimercate

20360

Pfizer Investigational Site, Turku

20520

Pfizer Investigational Site, Turku

21019

Pfizer Investigational Site, Somma Lombardo

25123

Pfizer Investigational Site, Brescia

26499

Pfizer Investigational Site, Rio, Patra

28040

Pfizer Investigational Site, Madrid

28041

Pfizer Investigational Site, Madrid

28100

Pfizer Investigational Site, Novara

30122

Pfizer Investigational Site, Venezia

30175

Pfizer Investigational Site, Mestre

33210

Pfizer Investigational Site, Tampere

39100

Pfizer Investigational Site, Bolzano

40126

Pfizer Investigational Site, Bologna

40133

Pfizer Investigational Site, Bologna

40139

Pfizer Investigational Site, Bologna

41110

Pfizer Investigational Site, Larissa

43201

Pfizer Investigational Site, Reus

44100

Pfizer Investigational Site, Ferrara

45500

Pfizer Investigational Site, Ioannina

50139

Pfizer Investigational Site, Florence

53100

Pfizer Investigational Site, Siena

58100

Pfizer Investigational Site, Grosseto

59100

Pfizer Investigational Site, Prato

66013

Pfizer Investigational Site, Chieti

70100

Pfizer Investigational Site, Kuopio

70110

Pfizer Investigational Site, Kuopio

71100

Pfizer Investigational Site, Foggia

80131

Pfizer Investigational Site, Napoli

84100

Pfizer Investigational Site, Salerno

85100

Pfizer Investigational Site, Potenza

90100

Pfizer Investigational Site, Oulu

Pfizer Investigational Site, Palermo

90127

Pfizer Investigational Site, Palermo

90150

Pfizer Investigational Site, Oulu

95123

Pfizer Investigational Site, Catania

95124

Pfizer Investigational Site, Catania

A-5020

Pfizer Investigational Site, Salzburg

A-3100

Pfizer Investigational Site, Sankt Pölten

A-1090

Pfizer Investigational Site, Vienna

A-4600

Pfizer Investigational Site, Wels

00260

Pfizer Investigational Site, Helsinki

01300

Pfizer Investigational Site, Vantaa

71 110

Pfizer Investigational Site, Heraklion

54 639

Pfizer Investigational Site, Thessaloniki

Unknown

Pfizer Investigational Site, Thessaloniki

Pfizer Investigational Site, Gorey

Pfizer Investigational Site, New Ross

Pfizer Investigational Site

06080

Pfizer Investigational Site, San Sisto

06126

Pfizer Investigational Site, Perugia

00161

Pfizer Investigational Site, Roma

07100

Pfizer Investigational Site, Sassari

4560-162

Pfizer Investigational Site, Guilhufe - PNF

4464-513

Pfizer Investigational Site, Matosinhos Municipality

1169-024

Pfizer Investigational Site, Lisbon

1990-050

Pfizer Investigational Site, Lisbon

4050-113

Pfizer Investigational Site, Porto

4900-858

Pfizer Investigational Site, Viana do Castelo

08025

Pfizer Investigational Site, Barcelona

08036

Pfizer Investigational Site, Barcelona

CH-5404

Pfizer Investigational Site, Baden

CH-4031

Pfizer Investigational Site, Basel

CH-3010

Pfizer Investigational Site, Bern

CH-9007

Pfizer Investigational Site, Sankt Gallen

CH-1011

Pfizer Investigational Site, Lausanne

CH-6900

Pfizer Investigational Site, Lugano

CH-8596

Pfizer Investigational Site, Münsterlingen

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00174304 - Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. | Biotech Hunter | Biotech Hunter